Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
6.63
Oct 30 • 3:59 PM ET Dollar change+0.13 Percentage change(2.00%)
Aftermarket Close
6.63
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
51.31M
Enterprise Value
32.44M
Income
-28.46M
Sales
0.21M
Book/sh
0.43
Cash/sh
2.54
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
43
IPO
Apr 29, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
244.33
P/B
15.49
P/C
2.61
P/FCF
-
EV/EBITDA
-
EV/Sales
154.48
Quick Ratio
1.61
Current Ratio
1.73
Debt/Eq
0.25
LT Debt/Eq
0.21
Option/Short
No / Yes
EPS (ttm)
-7.75
EPS next Y
-2.35
EPS next Q
-0.67
EPS this Y
76.67%
EPS next Y
18.12%
EPS next 5Y
42.24%
EPS past 3/5Y
7.81% -942.66%
Sales past 3/5Y
0.56% -
EPS Y/Y TTM
42.70%
Sales Y/Y TTM
-6.76%
EPS Q/Q
78.47%
Sales Q/Q
-34.62%
Insider Own
40.23%
Insider Trans
0.00%
Inst Own
23.10%
Inst Trans
-
ROA
-138.27%
ROE
-
ROIC
-587.82%
Gross Margin
-385.51%
Oper. Margin
-11411.11%
Profit Margin
-13747.34%
SMA20
2.48%
SMA50
-3.35%
SMA200
-3.49%
Trades
Shs Outstand
7.72M
Shs Float
4.63M
52W High
9.54 -30.50%
52W Low
3.62 82.90%
Volatility
16.97% 8.58%
ATR (14)
0.55
RSI (14)
50.80
Beta
2.01
Rel Volume
4.09
Avg Volume
11.82K
Volume
48,375
Perf Week
11.34%
Perf Month
0.36%
Perf Quarter
-3.98%
Perf Half Y
-2.64%
Perf YTD
0.29%
Perf Year
-11.46%
Perf 3Y
-44.75%
Perf 5Y
-93.19%
Perf 10Y
-
Prev Close
6.50
Price
6.63
Change %
2.00%
Consensus
Strong Buy
Avg. Price Target
$21.67
Implied Upside
+226.8%
Analysts3incl. previous ratings
Rating Distribution3 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 06, 2026Initiated
LLake Street
Buy$2.50-62.3%
Mar 31, 2026Initiated
HH.C. Wainwright
Buy$2.50-62.3%
Jun 24, 2024Initiated
AAscendiant Capital Markets
Buy$8.50+28.2%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Mona ChetanDirectorFeb 12 '26Buy0.40312,500125,000332,500Feb 17 04:51 PM
Potashnick RobertInterim CFOFeb 12 '26Buy0.40212,50085,000212,500Feb 17 04:49 PM
Kantor SusanDirectorFeb 12 '26Buy0.4096,15038,460174,037Feb 17 04:47 PM
BRYNELSEN CHARLESDirectorFeb 12 '26Buy0.401,000,000400,0001,050,000Feb 17 04:45 PM
Lucas Brent T.Chief Executive OfficerFeb 12 '26Buy0.4062,50025,000297,090Feb 17 04:45 PM
TAYLOR GLEN A10% OwnerFeb 12 '26Buy0.4018,750,0007,500,00021,703,607Feb 17 01:35 PM
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. It focuses on designing, developing, and marketing fully implantable medical devices that improve hearing. The company was founded in 1995 and is headquartered in White Bear Lake, MN.
CEO & DirectorMr. Brent T. Lucas Esq.
Chief Accounting OfficerMr. Robert M. Potashnick
VPMs. Karin Simonson